Co-Host: Yair Lotan, MD

At the conclusion of these activities, participants will be able to:

1. Evaluate treatment plans including the sequencing and combination of treatment options for individual patients.

2. Facilitate discussions with patients and caregivers regarding of bladder cancer treatment options.

CME Available: auau.auanet.org/node/26075

This educational series is supported by independent educational grants from:

Amgen

Astellas

AstraZeneca

Bristol-Myers Squibb

Genomic Health

Merck

Pfizer, Inc.

Sanofi Genzyme

UroGen Pharma